General Information of Drug Therapeutic Target (DTT) (ID: TTPRKM0)

DTT Name GABA transporter GAT-1 (SLC6A1)
Synonyms Solute carrier family 6 member 1; Sodium- and chloride-dependent GABA transporter 1; GAT1; GAT-1; GABT1; GABATR; GABA transporter 1
Gene Name SLC6A1
DTT Type
Successful target
[1]
Related Disease
Epilepsy/seizure [ICD-11: 8A61-8A6Z]
Multiple myeloma [ICD-11: 2A83]
BioChemical Class
Neurotransmitter:sodium symporter
UniProt ID
SC6A1_HUMAN
TTD ID
T62184
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MATNGSKVADGQISTEVSEAPVANDKPKTLVVKVQKKAADLPDRDTWKGRFDFLMSCVGY
AIGLGNVWRFPYLCGKNGGGAFLIPYFLTLIFAGVPLFLLECSLGQYTSIGGLGVWKLAP
MFKGVGLAAAVLSFWLNIYYIVIISWAIYYLYNSFTTTLPWKQCDNPWNTDRCFSNYSMV
NTTNMTSAVVEFWERNMHQMTDGLDKPGQIRWPLAITLAIAWILVYFCIWKGVGWTGKVV
YFSATYPYIMLIILFFRGVTLPGAKEGILFYITPNFRKLSDSEVWLDAATQIFFSYGLGL
GSLIALGSYNSFHNNVYRDSIIVCCINSCTSMFAGFVIFSIVGFMAHVTKRSIADVAASG
PGLAFLAYPEAVTQLPISPLWAILFFSMLLMLGIDSQFCTVEGFITALVDEYPRLLRNRR
ELFIAAVCIISYLIGLSNITQGGIYVFKLFDYYSASGMSLLFLVFFECVSISWFYGVNRF
YDNIQEMVGSRPCIWWKLCWSFFTPIIVAGVFIFSAVQMTPLTMGNYVFPKWGQGVGWLM
ALSSMVLIPGYMAYMFLTLKGSLKQRIQVMVQPSEDIVRPENGPEQPQAGSSTSKEAYI
Function Terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals.
KEGG Pathway
( )
Reactome Pathway
Na+/Cl- dependent neurotransmitter transporters (R-HSA-442660 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metadoxine DMM4QOJ Multiple myeloma 2A83 Approved [2]
Tiagabine DMKSQG0 Epilepsy 8A60-8A68 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [3]
CI-966 DM8T2KA Convulsion 8A68.Z Phase 1 [4]
------------------------------------------------------------------------------------
10 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
(R)-EF-1520 DM297MU Discovery agent N.A. Investigative [1]
(R)-nipecotic acid DMWGB40 Discovery agent N.A. Investigative [3]
(R/S) EF-1500 DMYDG27 Discovery agent N.A. Investigative [1]
(S)-EF-1520 DM0EQTM Discovery agent N.A. Investigative [1]
(S)-Piperidine-3-carboxylic acid DMST89H Discovery agent N.A. Investigative [3]
2,4-Diamino-butyric acid(GABA) DMAOGBP Discovery agent N.A. Investigative [5]
4-Hydroxy-piperidine-3-carboxylic acid DM9VQ0T Discovery agent N.A. Investigative [6]
LU32-176B DM2YOVC Discovery agent N.A. Investigative [7]
NIPECOTIC ACID DMPV450 Discovery agent N.A. Investigative [8]
SKF89976A DM0WNHQ Discovery agent N.A. Investigative [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Investigative Drug(s)

Molecular Expression Atlas (MEA) of This DTT

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DTT
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Multiple myeloma 2C82 Bone marrow 4.99E-02 -0.24 -0.62
------------------------------------------------------------------------------------

The Drug Transporter (DTP) Role of This DTT

DTT DTP Name Sodium- and chloride-dependent GABA transporter 1 (SLC6A1) DTP Info
Gene Name SLC6A1
1 Clinical Trial Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [9]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 929).
2 Company report (Alcobra pharma)
3 Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates: synthesis, in vitro pharmacology, and modeling. J Med Chem. 2004 Nov 4;47(23):5620-9.
4 Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol. 1994 Oct 14;269(2):219-24.
5 Glycine antagonists. Synthesis, structure, and biological effects of some bicyclic 5-isoxazolol zwitterions. J Med Chem. 1986 Feb;29(2):224-9.
6 Hydroxy- and amino-substituted piperidinecarboxylic acids as gamma-aminobutyric acid agonists and uptake inhibitors. J Med Chem. 1982 Oct;25(10):1157-62.
7 First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anti... J Pharmacol Exp Ther. 2005 Feb;312(2):866-74.
8 Epimeric cis-decahydroquinoline-5-carboxylic acids: effects on gamma-aminobutyric acid uptake and receptor binding in vitro. J Med Chem. 1981 Jul;24(7):788-94.
9 Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures. Am J Hum Genet. 2015 May 7;96(5):808-15.